Latest Publications

Share:

"Secret Sale" of Drug Counts as Prior Art in Patent Battle

On January 22, 2019, the U.S. Supreme Court affirmed the U.S. Court of Appeals for the Federal Circuit’s decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., No. 17-1229 (Jan. 22, 2019)....more

Secret Sales May Qualify as Prior Art Under Section 102(a) of the America Invents Act

On January 22, 2019, the U.S. Supreme Court affirmed the U.S. Court of Appeals for the Federal Circuit’s decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., No. 17-1229 (Jan. 22, 2019). ...more

USPTO Changes Claim Construction Standard Used In AIA Trial Proceedings

On October 10, 2018, the United States Patent & Trademark Office (USPTO) published a final rule that changes the current “broadest reasonable interpretation” or BRI standard used in inter partes review (IPR), post grant...more

Award Of Foreign Lost Profits Is Permissible Domestic Application Of U.S. Patent Act

On June 22, 2018, the U.S. Supreme Court handed down a 7-2 decision in WesternGeco LLC v. ION Geophysical Corp., No. 16-1011 (opinion by Justice Thomas), holding that a patent owner is entitled to recover lost foreign profits...more

Inter Partes Review Proceedings Survive, But Their Implementation Will Change

In a pair of decisions, the U.S. Supreme Court upheld the constitutionality of the inter partes review (IPR) process created by the America Invents Act but required the U.S. Patent & Trademark Office (USPTO) to make a...more

Federal Circuit Overrules Prior Decision, Holding Time-Bar Determinations Under § 315(b) Reviewable

Wi-Fi One, LLC v. Broadcom Corp., Nos. 2015-1944, -1945, -1946 (Fed. Cir., issued Jan. 8, 2018) - The U.S. Court of Appeals for the Federal Circuit, sitting en banc, held for the first time that time-bar determinations in...more

Federal Circuit Finds That Petitioners Have Burden Of Persuasion Of Unpatentability Of Claims Amended During An IPR Proceeding,...

In a much anticipated decision, the Federal Circuit has narrowly decided that a patent owner moving to amend claims during an inter partes review (IPR) does not have the burden of persuasion that the claims are patentable....more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide